Immunogenicity and Safety Study of Self-amplifying mRNA COVID-19 Vaccine Administered With Influenza Vaccines in Adults
Clinical trial NCT06279871 · COMPLETED
Trial details
- NCT number
- NCT06279871
- Sponsor
- Arcturus Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-03-27
- Primary completion
- 2024-10-09
- Enrollment
- 1514
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.